David W. Parke II, MD: That Special Something With Commentary by George A. Williams, MD
By George A. Williams, MD
David W. Parke II is the chief executive officer of the American Academy of Ophthalmology, headquartered in San Francisco.
Dr. Parke was photographed at the 44th annual Aspen Retinal Detachment Society meeting in Snowmass, Colo., in March 2016.
THAT SPECIAL SOMETHING
I have had the privilege and pleasure of knowing David W. Parke II, MD, since we were fellows together at the Medical College of Wisconsin from 1982 to 1983. Even then, it was apparent that David possessed that special something that defines leadership. His sense of academic and professional mission and purpose was, and is, truly exceptional. Whether he is serving as a residency program director, department chair, president of the American Academy of Ophthalmology (AAO), president of the Council of Medical Specialty Societies (representing more than 790,000 physicians), or chief executive officer of the AAO, David’s vision, candor, and drive bring out the best in everyone. As ophthalmologists, we are all well served by his dedication to our profession and patients.
—George A. Williams, MD
Related News
Researchers Test Stem Cell–Based Retinal Implant for Dry AMD With Encouraging Results
Physicians and researchers at the USC Roski Eye Institute have collaborated with other California institutions to show that a first-in-kind stem cell-based retinal i…
GenSight Biologics Announces Topline Results from Phase 3 Clinical Trial of GS010 in Patients with Leber Hereditary Optic Neuropathy (LHON)
GenSight Biologics announced that a phase 3 study of GS010 (rAAV2/2-ND4) in patients with Leber hereditary optic neuropathy (LHON) failed to meet its primary endpoint, with sh…
Treat-Extend-Stop Protocol for Wet AMD: Long-term Outcomes
A retrospective chart review was performed for 71 eyes of 67 patients with neovascular age-related macular degeneration (AMD) treated with intravitreal anti-vascular endotheli…
